Current concepts in organic acidurias: Understanding intra- and extracerebral disease manifestation

Journal of Inherited Metabolic Disease

Volumn 36, Issue 4, 2013, Pages 635-644

  Kölker, Stefan ^a   Burgard, Peter ^a   Sauer, Sven W ^a   Okun, Jürgen G ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

3 HYDROXYGLUTAMIC ACID; AMINO ACID DERIVATIVE; AMINO ACID TRANSPORTER; CARNITINE; GLUTAMIC ACID; HISTONE; HYDROXYMETHYLGLUTARYL COENZYME A SYNTHASE; LIPID; LYSINE; METHYLMALONIC ACID; MITOCHONDRIAL DNA; PROPIONIC ACID; REACTIVE OXYGEN METABOLITE;

ACIDURIA; AMINO ACID METABOLISM; AMINOACIDURIA; BLOOD BRAIN BARRIER; BRAIN DISEASE; BRAIN DYSFUNCTION; BRAIN TUMOR; CLINICAL FEATURE; CONFERENCE PAPER; DIET THERAPY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ENERGY METABOLISM; EPIGENETICS; EXCITOTOXICITY; GENE EXPRESSION; HISTONE MODIFICATION; HUMAN; MITOCHONDRIAL DNA DEPLETION; MULTIPLE ORGAN FAILURE; NEUROPATHOLOGY; NEUROTRANSMISSION; NONHUMAN; ORGANIC ACIDURIA; OXIDATIVE STRESS; SIGNAL TRANSDUCTION;

AMINO ACID METABOLISM, INBORN ERRORS; ANIMALS; BRAIN; BRAIN DISEASES, METABOLIC, INBORN; ENERGY METABOLISM; HUMANS;

EID: 84880239953     PISSN: 01418955     EISSN: 15732665     Source Type: Journal    
DOI: 10.1007/s10545-013-9600-8     Document Type: Conference Paper

References (96)

1. Bak LK, Schousboe A, Waagepetersen HS (2006) The glutamate/GABA-glutamine cycle: aspects of transport, neurotransmitter homeostasis and ammonia transfer. J Neurochem 98:641-653
2. Baumgartner D, Scholl-Bürgi S, Sass JO et al (2007) Prolonged QTc intervals and decreased left ventricular contractility in patients with propionic acidema. J Pediatr 150:192-197
3. Bayley JP, Devilee P (2010) Warburg tumours and the mechanism of mitochondrial tumour suppressor genes. Barking up at the right tree? Curr Opin Genet Dev 20:324-329
4. Baysal BE, Ferrell RE, Willett-Brozick JE et al (2000) Mutations in SDHD, a mitochondrial complex II gene, in hereditary paraganglioma. Science 287:848-851
5. Braissant O (2012) Creatine and guanidinoacetate transport at blood-brain and blood-cerebrospinal fluid barriers. J Inherit Metab Dis 35:655-664
6. Brock M, Buckel W (2004) On the mechanism of action of the antifungal agent propionate. Propionyl-CoA inhibits glucose metabolism in Aspergillus nidulans. Eur J Biochem 271:3227-3241
7. Brunengraber H, Roe CR (2006) Anaplerotic molecules: current and future. J Inherit Metab Dis 29:327-331
8. Burlina AP, Danieli D, Malfa F et al (2012) Glutaric aciduria type I and glioma: first report in a young adult patient. J Inherit Metab Dis 35(Suppl 1):S58, abstract
9. Chandler RJ, Venditti CP (2012) Pre-clinical efficacy and dosing of an AAV8 vector expressing human methylmalonyl-CoA mutase in a murine model of methylmalonic acidemia (MMA). Mol Genet Metab 107:617-619
10. Chandler RJ, Zerfas PM, Shanske S et al (2009) Mitochondrial dysfunction in mut methylmalonic acidemia. FASEB J 23:1252-1261
11. Chapman KA, Summar ML, Enns GM (2012) Propionic acidemia: to liver transplant or not to liver transplant? Pediatr Transpl 16:209-210
12. Cheema-Dhadli S, Leznoff CC, Halperin ML (1975) Effect of 2-methylcitrate on citrate metabolism: implications for the management of patients with propionic acidemia and methylmalonic aciduria. Pediatr Res 9:905-908
13. Chowdbury R, Yeoh KK, Tian YM et al (2012) The oncometabolite 2-hydroxyglutarate inhibits histone lysine demethylases. EMBO Rep 12:463-469
14. Cosson MA, Touati G, Lacaille F et al (2008) Liver hepatoblastoma and multiple OXPHOS deficiency in the follow-up of a patient with methylmalonic aciduria. Mol Genet Metab 95:107-109
15. Coude FX, Sweetman L, Nyhan WL (1979) Inhibition of propionyl-coenzyme A of N-acetylglutamate synthetase in rat liver mitochondria. A possible explanation for hyperammonemia in propionic and methylmalonic acidemia. J Clin Invest 64:1544-1551
16. Dang L, White DW, Gross S et al (2009) Cancer-associated IDH1 mutations produce 2-hydroxyglutarate. Nature 462:739-744
17. Danhauser K, Sauer SW, Haack TB et al (2012) DHTKD1 mutations cause 2-aminoadipic and 2-oxoadipic aciduria. Am J Hum Genet 91:1082-1087
18. Davison JE, Davies NP, Wilson M et al (2011) MR spectroscopy-based brain metabolite profiling in propionic acidaemia: metabolic changes in the basal ganglia during acute decompensation and effect of liver transplantation. Orphanet J Rare Dis 6:19
19. De Keyzer Y, Valayannopoulos V, Benoist JF et al (2009) Multiple OXPHOS deficiency in liver, kidney, heart, and skeletal muscle of patients with methylmalonic aciduria and propionic aciduria. Pediatr Res 66:91-95
20. Dewar D, Underhill SM, Goldberg MP (2003) Oligodendrocytes and ischemic brain injury. J Cereb Blood Flow Metab 23:263-274
21. Di Lisa F, Menabo R, Barbato R, Siliprandi N (1994) Contrasting effects of propionate and propionyl-L-carnitine on energy-linked processes in ischemic hearts. Am J Physiol 267:H455-461
22. Elpeleg O, Miller C, Hershkovitz E et al (2005) Deficiency of the ADP-forming succinyl-CoA synthase activity is associated with encephalomyopathy and mitochondrial DNA depletion. Am J Hum Genet 76:1081-1086
23. Harting I, Neumaier-Probst E, Seitz A et al (2009) Dynamic changes of striatal and extrastriatal abnormalities in glutaric aciduria type I. Brain 132:1764-1782
24. Hassel B, Brathe A, Petersen D (2002) Cerebral dicarboxylate transport and metabolism studied with isotopically labelled fumarate, malate and malonate. J Neurochem 82:410-419
25. Hayasaka K, Metoki K, Satoh T et al (1982) Comparison of cytosolic and mitochondrial enzyme alterations in the livers of propionic and methylmalonic acidemia: a reduction of cytochrome c oxidase activity. Tohoku J Exp Med 137:329-334
26. Heringer J, Boy NPS, Ensenauer R et al (2010) Use of guidelines improves the neurological outcome in glutaric aciduria type I. Ann Neurol 68:743-52
27. Hoffmann GF, Kölker S (2010) Protein-dependent inborn errors of metabolism. In: Warrel DA, Cox TM, Firth JD (eds) Oxford Textbook of Medicine, 5th edn. Oxford University Press, Oxford, pp 1559-1595
28. Hoffmann GF, Kölker S (2011) Cerebral organic acid disorders and other disorders of lysine catabolism. In: Saudubray JM, van den Berghe G, Walter JH (eds) Inborn Metabolic Diseases, 5th edn. Springer, Berlin, pp 333-347
29. Hoppel CL, Tandler B, Fujioka H, Riva A (2009) Dynamic organization of mitochondria in human heart and in myocardial disease. Int J Biochem Cell Biol 41:1949-1956
30. -, cblA, cblB). Pediatr Res 62:225-230
31. Hörster F, Garbade SF, Zwickler T et al (2009) Prediction of outcome in isolated methylmalonic acidurias: combined use of clinical and biochemical parameters. J Inherit Metab Dis 32:630-639
32. Kaelin WG Jr (2009) SDH5 mutations and familial paraganglioma: somewhere Warburg is smiling. Cancer Cell 16:180-182
33. Kasahara M, Sakamoto S, Kanazawa H et al (2012) Living-donor liver transplantation for propionic academia. Pediatr Transplant 16:230-234
34. Koeller DM, Woontner M, Crnic LS et al (2002) Biochemical, pathologic and behavioral analysis of a mouse model of glutaric academia type I. Hum Mol Genet 11:347-357
35. + dependence Of 3-hydroxyglutarate-induced excitotoxicity in primary neuronal cultures from chick embryo telencephalons. Pediatr Res 52:199-206
36. Kölker S, Schwab M, Hörster F et al (2003) Methylmalonic acid, a biochemical hallmark of methylmalonic aciduria but no inhibitor of mitochondrial respiratory chain. J Biol Chem 278:47388-47393
37. Kölker S, Koeller DM, Okun JG, Hoffmann GF (2004) Pathomechanisms of neurodegeneration in glutaryl-CoA dehydrogenase deficiency. Ann Neurol 55:7-12
38. Kölker S, Sauer SW, Surtees RA, Leonard JV (2006a) The aetiology of neurological complications of organic acidaemias - A role for the blood-brain barrier. J Inherit Metab Dis 29:701-704
39. Kölker S, Garbade SF, Greenberg CR et al (2006b) Natural history, outcome and therapeutic efficacy in children and adults with glutaryl-CoA dehydrogenase deficiency. Pediatr Res 59:840-847
40. Kölker S, Christensen E, Leonard JV et al (2011) Diagnosis and management of glutaric aciduria type I - revised recommendations. J Inherit Metab Dis 34:677-94
41. Kölker S, Boy SP, Heringer J et al (2012) Complementary dietary treatment using lysine-free, arginine-fortified amino acid supplements in glutaric aciduria type I - a decade of experience. Mol Genet Metab 107:72-80
42. Komatsuzaki S, Sakamoto O, Fuse N, Uematsu M, Matsubara Y, Ohura T (2012) Clinical reasoning: a young man with progressive subcortical lesions and optic nerve atrophy. Neurology 79:e63-68
43. Kossoff EH, Zupec-Kania BA, Amark PE et al (2009) Optimal clinical management of children receiving the ketogenic diet: recommendations of the International Ketogenic Diet Study Group. Epilepsia 50:304-317
44. Krähenbühl S, Chang M, Brass EP, Hoppel CL (1991) Decreased activities of ubiquinol:ferricytochrome c oxidoreductase (complex III) and ferrocytochrome c oxygen oxidoreductase (complex IV) in liver mitochondria from rats with hydroxycobalamin[c-lactam]-induced methylmalonic aciduria. J Biol Chem 266:20998-21003
45. Kranendijk M, Struys EA, Salomons GS, van der Knaap MS, Jakobs C (2012a) Progress in understanding D-2-hydroxyglutaric acidurias. J Inherit Metab Dis 35:571-587
46. Kranendijk M, Struys EA, van Schaftingen E et al (2012b) IDH2 mutations in patients with D-2-hydroxyglutaric aciduria. Science 330:336
47. Külkens S, Harting I, Sauer S et al (2005) Late-onset neurologic disease in glutaryl-CoA dehydrogenase deficiency. Neurology 64:2142-2144
48. Kyllerman M, Skjeldal O, Christensen E et al (2004) Long-term follow-up, neurological outcome and survival rate in 28 Nordic patients with glutaric aciduria type 1. Eur J Paediatr Neurol 8:121-129
49. Lamp J, Keyser B, Koeller DM, Ullrich K, Braulke T, Mühlhausen C (2011) Glutaric aciduria type 1 metabolites impair the succinate transport from astrocytic to neuronal cells. J Biol Chem 285:17777-17784
50. Marquard J, el Scheich T, Klee D et al (2011) Chronic pancreatitis in branched-chain organic acidurias - a case of methylmalonic aciduria and an overview of the literature. Eur J Pediatr 170:241-245
51. Meyburg J, Hoffmann GF (2005) Liver transplantation for inborn errors of metabolism. Transplantation 80(Suppl 1):S135-137
52. Mirandola SR, Melo DR, Schuck PF, Ferreira GC, Wajner M, Castilho RF (2008) Methylmalonate inhibits succinate-supported oxygen consumption by interfering with mitochondrial succinate uptake. J Inherit Metab Dis 31:44-54
53. Mitchell IJ, Cooper AJ, Griffiths MR (1999) The selective vulnerability of striatopallidal neurons. Prog Neurobiol 59:691-719
54. Mitchell GA, Gauthier N, Lesimple A, Wang SP, Mamer O, Qureshi I (2008) Hereditary and acquired diseases of acyl-coenzyme A metabolism. Mol Genet Metab 94:4-15
55. Morath MA, Okun JG, Müller IB et al (2008) Neurodegeneration and chronic renal failure in methylmalonic aciduria - a pathophysiological approach. J Inherit Metab Dis 31:35-43
56. Moroni I, Bugiani M, D'Incerti L et al (2004) L-2-hydroxyglutaric aciduria and brain malignant tumours: a predisposing condition ? Neurology 62:1882-1884
57. Neumaier-Probst E, Harting I, Seitz A, Ding C, Kölker S (2004) Neuroradiological findings in glutaric aciduria type I (glutaryl-CoA dehydrogenase deficiency. J Inherit Metab Dis 27:869-876
58. Nguyen NHT, Morland C, Gonzalez SV et al (2007) Propionate increases neuronal histone acetylation, but is metabolized oxidatively via glia. Relevance for propionic acidemia. J Neurochem 101:806-814
59. Nyhan WL, Barshop BA, Ozand PT (2005a) Propionic acidemia. In: Nyhan WL, Barshop BA, Ozand PT (eds) Atlas of metabolic diseases, 2nd edn. Hodder Education, London, pp 8-17
60. Nyhan WL, Barshop BA, Ozand PT (2005b) Methylmalonic acidemia. In: Nyhan WL, Barshop BA, Ozand PT (eds) Atlas of metabolic diseases, 2nd edn. Hodder Education, London, pp 18-29
61. O'Shea CJ, Sloan JL, Wiggs EA et al (2012) Neurocognitive phenotype of isolated methylmalonic aciduria. Pediatrics 129:e1541
62. Oberholzer VG, Levin B, Burgess A, Young WF (1967) Methylmalonic aciduria. An inborn error of metabolism leading to chronic metabolic acidosis. Arch Dis Child 42:482-504
63. Ohtsuki S (2004) New aspects of the blood-brain barrier transporters: its physiological roles in the central nervous system. Biol Pharm Bull 27:1489-1496
64. Okun JG, Hörster F, Farkas LM et al (2002) Neurodegeneration in methylmalonic aciduria involves inhibition of complex II and the tricarboxylic acid cycle, and synergistically acting excitotoxicity. J Biol Chem 277:14674-14680
65. Ostergaard E, Hansen FJ, Sorensen N et al (2007) Mitochondrial encephalomyopathy with elevated methylmalonic acid is caused by SUCLA2 mutations. Brain 130:853-861
66. Pardridge WM (1998) Blood-brain barrier carrier-mediated transport and brain metabolism of amino acids. Neurochem Res 23:635-644
67. Pearl PL, Gibson KM, Acosta MT et al (2003) Clinical spectrum of succinic semialdehyde dehydrogenase deficiency. Neurology 60:1413-1417
68. Pellerin L, Magistretti PJ (2012) Sweet sixteen for ANLS. J Cereb Blood Flow Metab 32:1152-1566
69. Pena L, Franks J, Chapman KA et al (2011) Natural history of propionic acidemia. Mol Genet Metab 105:5-9
70. Prada CE, Al Jasmi F, Kirk EP et al (2011) Cardiac disease in methylmalonic acidemia. J Pediatr 159:862-864
71. Reitman ZJ, Yan H (2010) Isocitrate dehydrogenase 1 and 2 mutations in cancer: alterations at a crossroads of cellular metabolism. J Natl Cancer Inst 102:932-941
72. Romano S, Valayannopoulos V, Touati G et al (2010) Cardiomyopathies in propionic aciduria are reversible after liver transplantation. J Pediatr 156:128-134
73. Rothman SM, Olney JW (1995) Excitotoxicity and the NMDA receptor - still lethal after eight years. Trends Neurosci 18:57-58
74. Sauer SW, Okun JG, Schwab MA et al (2005) Bioenergetics in glutaryl-coenzyme A dehydrogenase deficiency, a role for glutaryl-coenzyme A. J Biol Chem 280:21830-21836
75. Sauer SW, Okun JG, Fricker G et al (2006) Intracerebral accumulation of glutaric and 3-hydroxyglutaric acids secondary to limited flux across the blood-brain barrier constitute a biochemical risk factor for neurodegeneration in glutaryl-CoA dehydrogenase deficiency. J Neurochem 97:899-910
76. Sauer SW, Okun JG, Hoffmann GF, Kölker S, Morath MA (2008) Impact of short- and medium-chain organic acids, acylcarnitines, and acyl-CoAs on mitochondrial energy metabolism. Biochim Biophys Acta 1777:1276-1282
77. Sauer SW, Opp S, Haarmann A, Okun JG, Kölker S, Morath MA (2010a) Long-term exposure of human proximal tubule cells to hydroxycobalamin[c-lactam] as a possible model to study renal disease in methylmalonic acidurias. J Inherit Metab Dis 32:720-727
78. Sauer SW, Opp S, Mahringer A et al (2010b) Glutaric aciduria type I and methylmalonic aciduria: stimulation of cerebral import and export of accumulating neurotoxic dicarboxylic acids in in vitro models of the blood-brain barrier and the choroid plexus. Biochem Biophys Acta 1802:551-560
79. Sauer SW, Opp S, Hoffmann GF, Koeller DM, Okun JG, Kölker S (2011) Therapeutic modulation of cerebral L-lysine metabolism in a mouse model for glutaric aciduria type I. Brain 134:157-70
80. Schousboe A, Westergaard N, Waagepetersen HS, Larsson OM, Barken IJ, Sonnewald U (1997) Trafficking between glia and neurons of TCA cycle intermediates and related metabolites. Glia 21:99-105
81. Schwab MA, Sauer SW, Okun JG et al (2006) Secondary mitochondrial dysfunction in propionic aciduria: a pathogenic role for endogenous mitochondrial toxins. Biochem J 398:107-112
82. Segel R, Anikster Y, Zevin S et al (2011) A safety trial of high dose glyceryl triacetate for Canavan disease. Mol Genet Metab 103:203-206
83. Sokoloff L (1960) The metabolism of the central nervous system in vivo. In: Field J, Magoun HW, Hall VE (eds) Handbook of Physiology, Sect 1, vol II. Raven, New York, pp 161-168
84. Steenweg ME, Salomons GS, Yapici Z et al (2009) L-2-hydroxyglutaric aciduria: pattern of MR imaging abnormalities in 56 patients. Radiology 251:856-865
85. Steenweg ME, Jakobs C, Errami A et al (2010) Am overview on L-2-hydroxyglutarate dehydrogenase gene variants (L2HGDH): a genotype-phenotype study. Hum Mutat 31:380-390
86. Strauss KA, Donnelly P, Wintermark M (2010) Cerebral haemodynamics in patients with glutaryl-coenzyme A dehydrogenase deficiency. Brain 133:76-92
87. Strauss KA, Brumbaugh J, Duffy A et al (2011) Safety, efficacy and physiological actions of a lysine-free, arginine-rich formula to treat glutaryl-CoA dehydrogenase deficiency: focus on cerebral amino acid influx. Mol Genet Metab 104:93-106
88. 13C-NMR studies. Biochem J 312:75-61
89. Sutton VR, Chapman KA, Gropman AL et al (2012) Chronic management and health supervision of individuals with propionic acidemia. Mol Genet Metab 105:26-33
90. Topcu M, Aydin OF, Yalcinkaya C et al (2005) L-2-hydroxyglutaric aciduria: a report of 29 patients. Turk J Pediatr 47:1-7
91. Traber G, Baumgartner MR, Schwarz U, Pangalu A, Donath MY, Landau K (2011) Subacute bilateral visual loss in methylmalonic acidemia. J Neuroophthalmol 31:344-346
92. Wajner M, Goodmann SI (2011) Disruption of mitochondrial homeostasis in organic acidurias: insights from human and animal studies. J Bioenerg Biomembr 43:31-38
93. Williams Z, Hurley PE, Altiparmak UE et al (2009) Late onset optic neuropathy in methymalonic and propionic acidemia. Am J Ophthalmol 147:929-933
94. Xu W, Yang H, Liu Y et al (2011) Oncometabolite 2-hydroxyglutarate is a competitive inhibitor of alpha-ketoglutarate-dependent dioxygenases. Cancer Cell 19:17-30
95. Yodoya E (2006) Functional and molecular identification of sodium-coupled dicarboxylate transporters in rat primary cultured cerebral astrocytes and neurons. J Neurochem 97:162-173
96. Zinnanti WJ, Lazovic J, Housman C et al (2007) Mechanism of age-dependent susceptibility and novel treatment strategy in glutaric acidemia type I. J Clin Invest 117:3258-3270